Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 253

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 253
---
000. The Fourth Tranche Note is in substantially similar form to the Initial Note. Upon issuance of the note, the number of Class
A Ordinary Shares issuable upon exercise of the Series A Warrant automatically increased to approximately 159,223 (on a post Reverse Stock
Splits basis). The Fourth Tranche Note is included as Exhibit 4.1 in the Form 6-K filed on April 3, 2025, which is incorporated herein by reference.

Fifth Tranche

On July 16, 2025, the Company
consummated the fifth tranche of the 2024 Debt Financing under the terms of the Securities
Purchase Agreement. At the closing of the fifth tranche, the Company sold to the Investor a senior convertible note (the “Fifth
Tranche Note”) in the original principal amount of $2,000,000. The Note bears an interest rate of 14.75% per annum. The maximum
number of Class A Ordinary Shares of the Company, no par value, which this note is issuable into is 6,923,990, based on a conversion price
of $0.63 and assuming an interest rate of 14.75% through the fifty-four (54) month maturity of the Notes. Further the conversion price
of the Note is subject to proportional adjustment upon the occurrence of any stock split, stock dividend, stock combination and/or similar
transactions, and full-ratchet adjustment in connection with a subsequent offering at a per share price less than the fixed conversion
price then in effect. The holder of the Note may convert any portion of the outstanding portion of the Note into validly issued, fully
paid and non-assessable Class A Shares at the conversion price. No fractional Class A Shares are issuable upon any such conversion. If
the issuance would result in the issuance of a fraction of a Class A Share, the Company shall round such fraction of a Class A Share up
to the nearest whole share. The Fourth Tranche Note is included as Exhibit 4.1 in the Form 6-K filed on July 16, 2025, which is incorporated herein by reference.

Between November 7, 2024 and
the date of this prospectus, the Company received gross proceeds of $7,850,000 and issued an aggregate of 573,837 Class A Ordinary Shares
(on a post Reverse Stock Splits basis) to the Buyers.

The Company may receive up
to approximately $18,540,